Skip to main navigation
  • Home
    • Company
    • Need for Abuse Deterrent Products
    • Platforms
  • Technologies
    • Technology Platforms
    • AVERSION®
    • IMPEDE®
    • LIMITX™
  • Market Opportunity
    • Market Opportunity
    • Partnerships
    • Advocacy Groups
    • Patents
    • Business Development
  • Product Portfolio
    • Product Pipeline
    • OXAYDO®
    • NEXAFED® Product Line
    • LIMITX™ Products in Development
    • Important Safety Info
  • Clinical
    • Medical Meeting Calendar
  • Investors

    Investors

    • Investors
    • Press Releases
    • News & Events
    • Corporate Governance
      • Management
      • Directors
      • Committees
      • ContactBoard
    • Financial Information
      • SEC Filings
      • Quarterly Results
      • Key Ratios
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Ownership Profile
    • Risk Factors
    • Contact Us
 

acura

Contact Us
 
Share this on: Close window
Facebook Facebook
LinkedIn LinkedIn
Twitter Twitter

Investor Relations

  • Investors
  • Press Releases
  • News & Events
  • Corporate Governance
  • Financial Information
    • SEC Filings
    • Quarterly Results
    • Key Ratios
  • Stock Information
  • Risk Factors
  • Contact Us

Shareholder Tools

  • Email Alerts
  • Downloads
  • RSS News
  • Print Page
  • Share This

Financial Information

Here you will find a summary of Acura Pharmaceuticals, Inc.'s latest financial information.

Show all
  • Financial Results

Latest Earnings Release and 10-Q

Form Filing date View
10-Q May 02, 2005 View HTML
0001144204-05-013623.pdf
10-Q Nov 03, 2014 View HTML
0001144204-14-064695.pdf
EX-101.INS - XBRL INSTANCE DOCUMENT

Latest 10-K

Form Filing date View
10-K Mar 31, 1999 View HTML
0000950123-99-002901.pdf

Latest Proxy Statement

There are no SEC filings available.

Copyright © 1998-2023 Acura Pharmaceuticals. All rights reserved. Terms of Use and Privacy Policy Risk Factors Contact Us